Attenuation of oxidant-induced lung injury by the synthetic matrix metalloproteinase inhibitor BB-3103.
Department of Medicine and Research, VAMC Northport, New York, USA. hfoda@mail.som.sunysb.edu
H D
HD
Foda
E E
EE
Rollo
P
P
Brown
H
H
Pakbaz
H
H
Berisha
S I
SI
Said
S
S
Zucker
D000818:Animals; D006877:Hydroxamic Acids / Q000494:pharmacology*; D007700:Kinetics; D008168:Lung / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D016877:Oxidants / Q000037:antagonists & inhibitors / Q000633:toxicity*; D011480:Protease Inhibitors / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019820:Xanthine / Q000633:toxicity; D014969:Xanthine Oxidase
C108282:BB 3103; D006877:Hydroxamic Acids; D016877:Oxidants; D011480:Protease Inhibitors; D019820:Xanthine; D014969:Xanthine Oxidase; D008666:Metalloendopeptidases